Coastar Therapeutics Inc.
June 24, 2026
5B
Type: Start-Up Stadium Session
Focus Area:
Cell and Gene Therapy and Genome Editing
Coastar Therapeutics is a venture-backed biotech firm headquartered in San Diego, CA, dedicated to advancing next-generation gene delivery technology. The company has developed a novel eLNP technology incorporating the cell membrane for systemic non-viral gene delivery. The company also has a novel ENHEnS technology that can coat human cell membrane on each individual virus to evade immune system recognition and clearance.
Coastar is employing this cutting-edge platform to challenge the realms of CAR-T therapy and CRISPR gene editing. With its low toxicity and precision targeting features, the company is exploring in vivo therapy, potentially reducing treatment costs by a factor of 10, starting with in vivo CAR-T therapy and progressing to in vivo gene editing.
The company is a JLABS resident and participates NYU endless frontier labs accelerator.
Company HQ City:
San Diego
Company HQ State:
CA
Company HQ Country:
United States
Year Founded:
2019
CEO
Eddie Chung
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
){kind=logo}